Medtide (3880 HK)

Analysis

Health Care • Hong Kong

Medtide Inc. provides peptide CRDMO (contract research, development and manufacturing organization) services. The Company offers peptide NCE (new chemical entities) discovery synthesis, peptide CMC (chemistry, manufacturing, and controls) development and commercial manufacturing, and other services. Medtide serves customers across worldwide.

Refresh

Focused

No publications yet

There aren’t any sponsored reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00